相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diversity of HIV-1 Subtypes and Transmitted Drug-resistance Mutations Among Minority HIV-1 Variants in a Turkish Cohort
Rabia Can Sarinoglu et al.
CURRENT HIV RESEARCH (2022)
Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies
Sanjay Gupta et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Identification of FDA approved drugs and nucleoside analogues as potential SARS-CoV-2 A1pp domain inhibitor: An in silico study
Atul Kumar Singh et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2021)
HIV Protease: Historical Perspective and Current Research
Irene T. Weber et al.
VIRUSES-BASEL (2021)
Prevalence of transmitted HIV-1 drug resistance among treatment-naive individuals in China, 2000-2016
Huangbo Yuan et al.
ARCHIVES OF VIROLOGY (2021)
Phytochemicals present in Indian ginseng possess potential to inhibit SARS-CoV-2 virulence: A molecular docking and MD simulation study
Prem Prakash Kushwaha et al.
MICROBIAL PATHOGENESIS (2021)
Identification of Compounds from Curcuma longa with In Silico Binding Potential against SARS-CoV-2 and Human Host Proteins Involve in Virus Entry and Pathogenesis
S. Kumar et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
PubChem in 2021: new data content and improved web interfaces
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2021)
Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors
Tomas Bastys et al.
RETROVIROLOGY (2020)
Structure-based design approach to rational site-directed mutagenesis of β-lactoglobulin
Piotr Bonarek et al.
JOURNAL OF STRUCTURAL BIOLOGY (2020)
Gibbs Free Energy Calculation of Mutation in PncA and RpsA Associated With Pyrazinamide Resistance
Muhammad Tahir Khan et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 Tetrahydrofuranylglycine
Koushi Hidaka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: molecular dynamics insights
Sarentha Chetty et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2016)
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Edward Harder et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
Defective Hydrophobic Sliding Mechanism and Active Site Expansion in HIV-1 Protease Drug Resistant Variant Gly48Thr/Leu89Met: Mechanisms for the Loss of Saquinavir Binding Potency
Nathan E. Goldfarb et al.
BIOCHEMISTRY (2015)
Effect of T68A/N126Y mutations on the conformational and ligand binding landscape of Coxsackievirus B3 3C protease
Soumendranath Bhakat
MOLECULAR BIOSYSTEMS (2015)
g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations
Rashmi Kumari et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
A Novel Angiotensin I-Converting Enzyme Mutation (S333W) Impairs N-Domain Enzymatic Cleavage of the Anti-Fibrotic Peptide, AcSDKP
Sergei M. Danilov et al.
PLOS ONE (2014)
A Comparative Molecular Dynamics, MM-PBSA and Thermodynamic Integration Study of Saquinavir Complexes with Wild-Type HIV-1 PR and L10I, G48V, L63P, A71V, G73S, V82A and I84V Single Mutants
Haralambos Tzoupis et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2013)
Principal component and clustering analysis on molecular dynamics data of the ribosomal L11•23S subdomain
Antje Wolf et al.
JOURNAL OF MOLECULAR MODELING (2013)
The new and less toxic protease inhibitor saquinavir-NO maintains anti-HIV-1 properties in vitro indistinguishable from those of the parental compound saquinavir
Filippo Canducci et al.
ANTIVIRAL RESEARCH (2011)
Validation of the GROMOS 54A7 Force Field with Respect to β-Peptide Folding
Wei Huang et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2011)
Molecular Dynamics and Free Energy Studies on the Wild-Type and Mutated HIV-1 Protease Complexed with Four Approved Drugs: Mechanism of Binding and Drug Resistance
Stefano Alcaro et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Identification of Structural Mechanisms of HIV-1 Protease Specificity Using Computational Peptide Docking: Implications for Drug Resistance
Sidhartha Chaudhury et al.
STRUCTURE (2009)
Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir
Fengling Liu et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: Possible contributions to drug resistance and a potential new target site for drugs
AL Perryman et al.
PROTEIN SCIENCE (2004)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
A solution NMR study of the binding kinetics and the internal dynamics of an HIV-1 protease-substrate complex
E Katoh et al.
PROTEIN SCIENCE (2003)
A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance
S Muzammil et al.
BIOCHEMISTRY (2003)
Drug resistance in HIV-1 protease: Flexibility-assisted mechanism of compensatory mutations
S Piana et al.
PROTEIN SCIENCE (2002)
Electrostatics of nanosystems: Application to microtubules and the ribosome
NA Baker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
